Redmond Asset Management’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,157
| Closed | -$430K | – | 156 |
|
|
2024
Q1 | $430K | Buy |
36,157
+2,077
| +6% | +$24.7K | 0.14% | 126 |
|
|
2023
Q4 | $637K | Hold |
34,080
| – | – | 0.21% | 116 |
|
|
2023
Q3 | $323K | Buy |
34,080
+70
| +0.2% | +$664 | 0.12% | 136 |
|
|
2023
Q2 | $486K | Hold |
34,010
| – | – | 0.16% | 125 |
|
|
2023
Q1 | $524K | Hold |
34,010
| – | – | 0.18% | 127 |
|
|
2022
Q4 | $457K | Buy |
+34,010
| New | +$457K | 0.16% | 132 |
|
|
2021
Q4 | – | Sell |
-7,878
| Closed | -$250K | – | 198 |
|
|
2021
Q3 | $250K | Buy |
7,878
+128
| +2% | +$4.06K | 0.08% | 174 |
|
|
2021
Q2 | $663K | Buy |
+7,750
| New | +$663K | 0.19% | 142 |
|